ARCHIVES

INSPIRE Enrollment Stopped; Thromboembolism Risk Cited

This article is from The Cancer Letter archive.

Vol. 34 No. 2 | February 25, 2011

Download PDF Visit The Full Archive

Related Articles

Tacoma Hospital Finds Cancer DRGs Are Profitable

February 17, 1984

FDA Approves DNA Test For Two Types of HPV

March 27, 2009

No Benefit For Cetuximab In Early-Stage Colon Cancer

December 25, 2009

Hawkins Calls For Joins Cancer Center-Community Effort To Develop Better Technology Transfers

May 29, 1981

NCAB Committee Approves NCI Plans For Organ Systems

February 5, 1988

Sanofi: Zaltrap Price Reflects Competing Drugs In Second-Line Metastatic Colon Cancer

November 1, 2012